Posted in | News | Gas Sensor | Chemical Sensor

CDS Handheld Trace Vapor Detector Awarded SAFETY Act DT&E Designation

Chemring Detection Systems, Inc. ("CDS"), part of Chemring Group PLC, is pleased to announce that JUNO® has been awarded SAFETY Act Developmental Testing and Evaluation (DT&E) Designation by the US Department of Homeland Security, Science and Technology (DHS S&T).

JUNO® is a handheld trace vapor detector based on the advanced sensor technology – Differential Mobility Spectrometry (DMS).  The Benefits of DMS over currently available products include improved sensitivity and selectivity resulting in trace level detection and low false alarm rates.

The SAFETY Act, also known as Support Anti-Terrorism by Fostering Effective Technologies, is a law enacted by Congress as part of the Homeland Security Act of 2002 (Title VII, Subtitle G).

The designation, which is valid until October 31, 2015, coincides with the official product release of JUNO®. "We are very pleased to receive the DT&E Designation under the SAFETY Act for JUNO®. This certainly reinforces our belief that Differential Mobility Spectrometry (DMS), inside JUNO®, represents an excellent platform for trace vapor detection," says Dan McKenrick , President of Chemring North America.

JUNO® headlines CDS' new point-of-need instrumentation product family being introduced at Pittcon®2013 (www.pittcon.org) which will include a handheld Raman (THOR-1064) and a UV Fluorescence Particle Detector and Collector (iCollector). Visit BOOTH #4210 for product demonstrations and information on how CDS' products solve point-of-need measurement needs in the security, environmental, and industrial monitoring applications or visit http://www.chemringds.com/Products/ for more information.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.